nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Acute myeloid leukemia with a cryptic NUP98/PRRX2 rearrangement developing after low-dose methotrexate therapy for rheumatoid arthritis
|
Chonabayashi, Kazuhisa |
|
|
98 |
12 |
p. 2841-2843 |
artikel |
2 |
Acute porphyrias: a German monocentric study of the biochemical, molecular genetic, and clinical data of 62 families
|
Bronisch, Olivia |
|
|
98 |
12 |
p. 2683-2691 |
artikel |
3 |
Aggressive systemic mastocytosis: a diagnostic challenge in a patient with myotonic dystrophy type 2: a case report
|
Tran, Christin Le Hoa |
|
|
98 |
12 |
p. 2825-2827 |
artikel |
4 |
A new SH2D1A mutation in a female adult XLP disease with hemophagocytic lymphohistiocytosis and NK-cell leukemia
|
Liang, Jin-Hua |
|
|
98 |
12 |
p. 2829-2831 |
artikel |
5 |
Atypical primary cutaneous cryptococcosis during ibrutinib therapy for chronic lymphocytic leukemia
|
Peri, Anna Maria |
|
|
98 |
12 |
p. 2847-2849 |
artikel |
6 |
Correction to: prediction of thrombosis risk in patients with paroxysmal nocturnal hemoglobinuria
|
Huang, Yuzhou |
|
|
98 |
12 |
p. 2857 |
artikel |
7 |
CRISPR/Cas9 gene correction of HbH-CS thalassemia-induced pluripotent stem cells
|
Yingjun, Xie |
|
|
98 |
12 |
p. 2661-2671 |
artikel |
8 |
Daratumumab plus bortezomib, melphalan, and prednisone in East Asian patients with non-transplant multiple myeloma: subanalysis of the randomized phase 3 ALCYONE trial
|
Fujisaki, Tomoaki |
|
|
98 |
12 |
p. 2805-2814 |
artikel |
9 |
Double hit B cell precursor leukemia/lymphoma in a patient with a prior diagnosis of follicular lymphoma: a diagnostic and therapeutic dilemma
|
Bravo-Perez, Carlos |
|
|
98 |
12 |
p. 2837-2839 |
artikel |
10 |
Early risk stratification for diffuse large B-cell lymphoma integrating interim Deauville score and International Prognostic Index
|
Yim, Sung Kyun |
|
|
98 |
12 |
p. 2739-2748 |
artikel |
11 |
Enrichment of circulating myeloma cells by immunomagnetic beads combined with flow cytometry for monitoring minimal residual disease and relapse in patients with multiple myeloma
|
Wang, Ningning |
|
|
98 |
12 |
p. 2769-2780 |
artikel |
12 |
Genetic modulators of fetal hemoglobin expression and ischemic stroke occurrence in African descendant children with sickle cell anemia
|
Nicolau, Marta |
|
|
98 |
12 |
p. 2673-2681 |
artikel |
13 |
Hemoglobin Kirklareli [Α2 59(E7) His>Leu; HBA2:c.176A>T] in a Brazilian child with severe dyspnea and low O2 saturation
|
Pedroso, G. A. |
|
|
98 |
12 |
p. 2853-2855 |
artikel |
14 |
Is bendamustine-rituximab a reasonable treatment in selected older patients with diffuse large B cell lymphoma? Results from a multicentre, retrospective study
|
Zeremski, Vanja |
|
|
98 |
12 |
p. 2729-2737 |
artikel |
15 |
Magnetic resonance imaging reveals distinct bone marrow patterns in indolent and advanced systemic mastocytosis
|
Riffel, Philipp |
|
|
98 |
12 |
p. 2693-2701 |
artikel |
16 |
Midostaurin in combination with intensive chemotherapy is safe and associated with improved remission rates and higher transplantation rates in first remission—a multi-center historical control study
|
Berger, Tamar |
|
|
98 |
12 |
p. 2711-2717 |
artikel |
17 |
New insights inside the interdigitating dendritic cell sarcoma—pooled analysis and review of literature
|
Muhammed, Amr |
|
|
98 |
12 |
p. 2641-2651 |
artikel |
18 |
Non-invasive urinary biomarkers of renal function in sickle cell disease: an overview
|
Laurentino, Marília Rocha |
|
|
98 |
12 |
p. 2653-2660 |
artikel |
19 |
Outcomes of allogeneic stem cell transplantation for DLBCL: a multi-center study from the Kyoto Stem Cell Transplantation Group
|
Izumi, Kiyotaka |
|
|
98 |
12 |
p. 2815-2823 |
artikel |
20 |
Peripheral neuropathy following bortezomib therapy in multiple myeloma patients: association with cumulative dose, heparanase, and TNF-α
|
Zhao, Weiwei |
|
|
98 |
12 |
p. 2793-2803 |
artikel |
21 |
Prognostic value of U2AF1 mutant in patients with de novo myelodysplastic syndromes: a meta-analysis
|
Wang, Huifang |
|
|
98 |
12 |
p. 2629-2639 |
artikel |
22 |
Residual methylation of tumor suppressor gene promoters, RASSF6 and RASSF10, as novel biomarkers for minimal residual disease detection in adult acute lymphoblastic leukemia
|
Younesian, Samareh |
|
|
98 |
12 |
p. 2719-2727 |
artikel |
23 |
Response to interferon treatment in essential thrombocythemia with inv(3)(q21q26)
|
Gangaraju, Radhika |
|
|
98 |
12 |
p. 2845-2846 |
artikel |
24 |
RVD induction and autologous stem cell transplantation followed by lenalidomide maintenance in newly diagnosed multiple myeloma: a phase 2 study of the Finnish Myeloma Group
|
Luoma, Sini |
|
|
98 |
12 |
p. 2781-2792 |
artikel |
25 |
Secondary haploidentical hematopoietic stem cell transplantation in patients with relapse or graft failure after initial hematopoietic stem cell transplantation
|
Hou, Chang |
|
|
98 |
12 |
p. 2833-2836 |
artikel |
26 |
Single-agent ibrutinib in RESONATE-2™ and RESONATE™ versus treatments in the real-world PHEDRA databases for patients with chronic lymphocytic leukemia
|
Salles, Gilles |
|
|
98 |
12 |
p. 2749-2760 |
artikel |
27 |
Socioeconomic Position is Positively Associated with Monoclonal Gammopathy of Undetermined Significance in a Population-based Cohort Study
|
Schmidt, Börge |
|
|
98 |
12 |
p. 2761-2767 |
artikel |
28 |
Transcriptional alteration of DNA repair genes in Philadelphia chromosome negative myeloproliferative neoplasms
|
Kirschner, Martin |
|
|
98 |
12 |
p. 2703-2709 |
artikel |
29 |
Unexpected response of extramedullary plasmacytoma in patients with lung cancer who received nivolumab
|
Yamaguchi, Ou |
|
|
98 |
12 |
p. 2851-2852 |
artikel |